Cupid lifts FY27 revenue guidance to ₹880 crore-plus in November

Cupid Limited lifted its FY27 revenue guidance in November 2026 to at least ₹880 crore, 47% above the original ₹600 crore target, alongside a ₹275 crore-plus net-profit target. The company reported H1 FY27 total income of ₹365.95 crore and set FY29 revenue guidance at at least ₹1,950 crore.

Why did Cupid raise its FY27 guidance?

Cupid raised its FY27 guidance because management expects H2 FY27 to be significantly stronger than H1, supported by the planned Q3 FY27 commissioning of the Palava facility and consumer-business sales through V2 Retail and Style Baazar. The latest target is at least ₹880 crore of revenue and ₹275 crore-plus of net profit, versus the previous 30 September 2026 guidance of ₹800 crore-plus and ₹250 crore-plus, respectively.

The November 2026 revenue target is Cupid's fifth disclosed FY27 guidance level and is ₹280 crore above the original ₹600 crore estimate. Net-profit guidance has moved from ₹180 crore initially to ₹275 crore-plus. Cupid says revenue guidance denotes a minimum expected level, while its projections depend on retail rollout, manufacturing capacity and other forward-looking assumptions.

Cupid's original-to-latest revenue increase equals 47%, as stated in the release. Management cited festive-season demand, expanding organised-retail partnerships and higher manufacturing capability as reasons it expects a larger H2 FY27 contribution, but the company has not reported those second-half results.

How much of Cupid's FY27 guidance was achieved in H1?

Cupid achieved about 42% of its revised FY27 revenue guidance in H1 FY27, reporting total income of ₹365.95 crore against a revenue target of at least ₹880 crore. H1 FY27 net profit of ₹100.37 crore represented around 36% of the ₹275 crore-plus full-year net-profit guidance.

H1 FY27 total income rose 136% from ₹154.98 crore in H1 FY26, while net profit increased 156% from ₹39.14 crore. Operating income, which Cupid defines as revenue from operations, rose 137% to ₹342.58 crore. The company reported earnings before interest, tax, depreciation and amortisation of ₹114.83 crore for H1 FY27, up 156% year on year.

The second quarter was larger than the first quarter. Q2 FY27 total income was ₹208.97 crore, up 33% from ₹156.98 crore in Q1 FY27 and 132% from ₹90.23 crore in Q2 FY26. Q2 FY27 net profit reached ₹56.22 crore, compared with ₹44.15 crore in Q1 FY27 and ₹24.13 crore a year earlier.

Cupid's Q2 FY27 net-profit margin was 30%, compared with 29% in Q1 FY27 and 29% in Q2 FY26. For H1 FY27, the margin was 29%, versus 27% in H1 FY26. Management attributed the progression to product mix, sourcing efficiencies and scale benefits as its Consumer Healthcare and fast-moving consumer goods portfolio expands in organised retail channels.

What is expected to drive Cupid's H2 FY27 growth?

Cupid expects V2 Retail and Style Baazar to help drive H2 FY27 growth, with V2 Retail projected to generate at least ₹400 crore over the next 12 months and Style Baazar expected to contribute about ₹200 crore in FY27. These are company expectations rather than reported sales, and the V2 Retail estimate covers a 12-month period rather than FY27 alone.

Cupid signed its long-term exclusive partnership with V2 Retail on 4 November 2026. The agreement provides around 400 square feet of dedicated space in each existing and future V2 Retail store, covering 425-plus stores and more than 1.7 lakh square feet at full rollout. Supplies started in November 2026, and Cupid expects products to be available in all 425-plus stores by mid-December 2026.

Cupid also expects its Consumer Healthcare and fast-moving consumer goods portfolio to be available across more than 290 Style Baazar stores, while that network is expected to exceed 500 stores over the next two to three years. Cupid had 1.01 crore convertible warrants allotted in Baazar Style Retail Limited, involving a total investment commitment of ₹331.53 crore; 45 lakh warrants had been converted by September and October 2026 at an aggregate conversion value of ₹147.71 crore.

Domestic business contributed ₹224.64 crore in H1 FY27, or 67% of sales, compared with a 41% share in FY26. Consumer Healthcare and fast-moving consumer goods accounted for ₹166.88 crore, or 49% of H1 FY27 sales. International business contributed ₹112.73 crore, or 33%, supported by institutional demand through the PFSCM agreement, South Africa's 2025-30 national programme and export price revisions.

How will the Palava facility affect Cupid's capacity?

Cupid expects its Palava manufacturing facility in Maharashtra to be commissioned in Q3 FY27, increasing annual male-condom capacity to about 1.25 billion units from 480 million units. Female-condom capacity is expected to rise to about 125 million units from 52 million units at the Sinnar facility.

The planned Palava site spans about 1.70 lakh square feet and will have dual-polymer dipping lines for natural-rubber-latex and nitrile products. Cupid said the lines would support its nitrile female condom under development and potential participation in additional global nitrile tenders. The release does not disclose a commissioning date within Q3 FY27, a utilisation forecast or a production ramp-up schedule.

Cupid said Palava capacity is expected to support higher H2 FY27 volumes for international tenders and its domestic consumer business. Separately, the board gave in-principle approval in August 2026 for a proposed South African manufacturing venture in which Cupid could own up to 49%, with the local partner arranging capital expenditure and working capital.

The board also approved exploration of a proposed medical-devices manufacturing project in West Bengal in August 2026 through a wholly owned subsidiary. Land, commercial terms and financial feasibility remain under evaluation. In July 2026, Cupid also made a follow-on investment of USD 5 million in GII Healthcare Investment Limited using internal accruals.

What are Cupid's FY28 and FY29 targets?

Cupid's revised guidance calls for revenue of at least ₹1,305 crore in FY28 and at least ₹1,950 crore in FY29, with approximate net profit of ₹390 crore and ₹605 crore, respectively. Cupid says its FY28 and FY29 revenue figures are minimum expected levels, while the two net-profit figures are approximate.

The FY28 revenue target is ₹220 crore above Cupid's earlier ₹1,085 crore projection, and the FY29 target is ₹450 crore above its earlier ₹1,500 crore projection. Management linked the revisions to organised-retail partnerships, the Palava facility, domestic consumer expansion and international healthcare operations, but did not provide a segment-by-segment revenue bridge for either year.

Management also said Cupid intends to become debt-free over time. The release does not specify a target date, debt balance or repayment schedule. Its disclosed near-term milestones are the Q3 FY27 Palava commissioning and the targeted mid-December 2026 completion of availability across V2 Retail's 425-plus stores.

Conclusion

Cupid's November 2026 guidance increase combines reported H1 FY27 growth with management's expectation of a substantially larger H2 FY27. Total income rose 136% to ₹365.95 crore and net profit rose 156% to ₹100.37 crore, while domestic business increased to 67% of H1 sales from 41% in FY26. The revised FY27 revenue floor of ₹880 crore relies on retail distribution and manufacturing expansion delivering as planned.

Investors will next watch for the Q3 FY27 commissioning of the Palava facility, product availability across 425-plus V2 Retail stores by mid-December 2026, and reported contributions from V2 Retail and Style Baazar. The proposed South African venture and West Bengal medical-devices project remain unresolved because commercial, financial and feasibility work is still in progress.